# A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)

> **NCT00799578** · PHASE1,PHASE2 · COMPLETED · sponsor: **Joel Lavine** · enrollment: 13 (actual)

## Conditions studied

- Fatty Liver

## Interventions

- **DRUG:** Cysteamine

## Key facts

- **NCT ID:** NCT00799578
- **Lead sponsor:** Joel Lavine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-06
- **Final completion:** 2010-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799578, "A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00799578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*